C. Rice

发表

Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii

D. Kyle, C. Rice, E. Troth, 2020, Pathogens.

The transcriptome of Balamuthia mandrillaris trophozoites for structure-based drug design

P. Myler, D. Kyle, I. Phan, 2020, bioRxiv.

Exploitation of Mangrove Endophytic Fungi for Infectious Disease Drug Discovery

D. Kyle, L. Shaw, B. Baker, 2018, Marine drugs.

Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond Citation

Alessandro, Serge, Tyler B. Hughes, 2016 .

Polychlorinated cyclopentenes from a marine derived Periconia sp. (strain G1144).

D. Kyle, H. Raja, N. Oberlies, 2022, Phytochemistry.

Turning Back the Clock: The Effect of the COVID-19 Response in Sub-Saharan Africa and Other Low-Income Countries

C. Rice, Sanghvi Reema, 2021 .

Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae

D. Kyle, M. Hull, C. Rice, 2020, bioRxiv.

Conservation of Ancient Genetic Pathways for Intracellular Persistence Among Animal Pathogenic Bordetellae

D. Kyle, B. Linz, E. Harvill, 2019, Front. Microbiol..

Keikipukalides, Furanocembrane Diterpenes from the Antarctic Deep Sea Octocoral Plumarella delicatissima

D. Kyle, B. Baker, C. Rice, 2017, Journal of natural products.

Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

Manuel Llinás, George Papadatos, Sundari Suresh, 2016, PLoS pathogens.

In Vitro Screening of the Open-Source Medicines for Malaria Venture Malaria and Pathogen Boxes To Discover Novel Compounds with Activity against Balamuthia mandrillaris

D. Kyle, C. Rice, F. Lares-Villa, 2020, Antimicrobial Agents and Chemotherapy.

Phenotypic Screens Reveal Posaconazole as a Rapidly Acting Amebicidal Combination Partner for Treatment of Primary Amoebic Meningoencephalitis

D. Kyle, R. Guy, C. Rice, 2018, The Journal of infectious diseases.

Structural and functional studies of histidine biosynthesis in Acanthamoeba spp. demonstrates a novel molecular arrangement and target for antimicrobials

D. Rice, C. Roberts, P. Baker, 2018, PloS one.

Characterisation of sterol biosynthesis and validation of 14α-demethylase as a drug target in Acanthamoeba

C. Roberts, R. Edrada-Ebel, Tong Zhang, 2017, Scientific Reports.

Bis-Benzimidazole Hits against Naegleria fowleri Discovered with New High-Throughput Screens

D. Kyle, D. Boykin, C. Rice, 2015, Antimicrobial Agents and Chemotherapy.

Synthesis, Cytotoxicity and Genotoxicity of 10-Aza-9-oxakalkitoxin, An N,N,O-Trisubstituted Hydroxylamine Analog, or Hydroxalog, of a Marine Natural Product.

F. Valeriote, S. Pegan, C. Rice, 2020, Journal of the American Chemical Society.

Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii

D. Kyle, C. Rice, E. Troth, 2020, bioRxiv.

Acanthamoeba spp. aggregate and encyst on contact lens material increasing resistance to disinfection

Reed Pifer, C. Rice, Valerie Harris, 2022, Frontiers in Microbiology.

Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba

P. Myler, D. Kyle, I. Phan, 2020, bioRxiv.

Characterization of Glucokinases from Pathogenic Free-Living Amoebae

Jennifer E. Golden, M. M. Khalifa, I. Phan, 2022, Antimicrobial agents and chemotherapy.

Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes

D. Kyle, F. Gamarro, D. González-Pacanowska, 2023, Frontiers in Microbiology.

The transcriptome of Balamuthia mandrillaris trophozoites for structure-guided drug design

C. Rice, Jacquelyn McDonald, R. E. Noorai, 2021, Scientific Reports.

Modelling dynamics between free-living amoebae and bacteria.

A. Byrne, C. Rice, Philip E. Paré, 2024, Environmental microbiology.